Management of Hyperlipidaemia using KNEA: A case report

Area of Science:

• Integrative Medicine
• Cardiovascular Health
• Traditional Siddha Medicine

Background:

• Hyperlipidemia significantly elevates the risk of atherosclerotic cardiovascular disease (ASCVD) and stroke.
• Dyslipidemia is a primary contributor to cardiovascular diseases.
• Siddha medicine offers potential therapeutic interventions for managing lipid disorders.

Purpose of the Study:

• To present a case study on the efficacy of Siddha therapeutic regimens KNEA in managing hyperlipidemia.
• To evaluate the impact of KNEA on key lipid profile parameters.

Main Methods:

• A single-patient case report detailing the administration of Siddha medications KNEA.
• Monitoring of lipid profile, including total cholesterol (TC), LDL-C, and HDL-C levels before and after treatment.

Main Results:

• Successful reduction in total cholesterol from 205 mg/dL to 27 mg/dL (a decrease of 178 mg/dL).
• Significant decrease in LDL-C from 127 mg/dL to 19 mg/dL (a reduction of 108 mg/dL).
• Improvement in HDL-C levels, increasing from 33 mg/dL to 42 mg/dL.

Conclusions:

• The Siddha therapeutic regimen KNEA demonstrated significant antihyperlipidemic effects in this case.
• KNEA possesses potential hepatoprotective, antioxidant, and nephroprotective properties beneficial in hyperlipidemia management.
• This case suggests KNEA as a viable complementary therapy for hyperlipidemia within the Siddha medical system.